| Mrs Christy Lynn Piti, BS, RP | |
|
224 N Park Ave, Fremont, NE 68025-4964 | |
| (402) 753-2800 | |
| (402) 753-2863 |
| Full Name | Mrs Christy Lynn Piti |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 224 N Park Ave, Fremont, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154414993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10259 (Nebraska) | Primary |
| 183500000X | Pharmacist | 9498 (Arizona) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Christy Lynn Piti, BS, RP 224 N Park Ave, Fremont, NE 68025-4964 Ph: (402) 753-2800 | Mrs Christy Lynn Piti, BS, RP 224 N Park Ave, Fremont, NE 68025-4964 Ph: (402) 753-2800 |
News Archive
The Synopsys Simpleware Product Group is pleased to announce the release of Simpleware R-2021.03, which adds brand-new fully automated segmentation and landmarking tools for new anatomies, as well as improvements to the software's established family of AI-enabled solutions for orthopedic and cardiology-based workflows.
The ongoing debate about breast cancer diagnostics has left many women confused — particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps but cannot conclusively pinpoint which ones are cancerous. To help resolve this uncertainty, researchers have developed a pill that could improve imaging techniques so that only cancerous tumors light up.
The drug known as rapamycin is widely used by cancer and transplant patients, and there are hints that it might even help us put off old age and live longer. But, it also comes with a downside: rapamycin leads to diabetes in as many as 15 percent of the people who take it.
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
A recent article in the Journal of Thrombosis and Haemostasis determined that drinkers of wine benefit from its cardio-protective effects, more so than those who drink beer or other spirits, and may also live longer.
› Verified 3 days ago
Dr. Stephanie Lynn Meyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 | |
Dominic Tang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1531 N Bell St, Fremont, NE 68025 Phone: 402-727-1995 Fax: 402-753-0073 | |
Annette Seely, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1531 N Bell St, Fremont, NE 68025 Phone: 402-727-1995 Fax: 402-753-0073 | |
Aaron Stalets, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 Fax: 402-721-0785 | |
Mrs. Amy Mcmurtry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 | |
Craig Morgan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-7266 |